All lobbying filings
Manatt, Phelps, and Phillips
Manatt, Phelps, and Phillips filed a Q1 report for Denali Therapeutics on April 6, 2026, reporting $70,000 in lobbying income.
Lobbying for Denali Therapeutics · Biopharmaceutical Company
Filing · LD-2 quarterly report
Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 6, 2026
Income
$70,000
What the client paid this registrant for the period.
Client based in
California
Lobbying activity
1
Rare Pediatric Disease Priority Review Voucher (PRV) Program Reauthorization; Rare disease drug development